# Clinical trials recruiting in South Carolina: 1,276 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 1,276 trials recruiting or not yet recruiting with a site in South Carolina, as read on November 19, 2026.

## The full list

Clinical trials recruiting in South Carolina: 1,276 rows for $63.80, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 22 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/state/south-carolina

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 1,276
- Recruiting or not yet: 1,276
- Read on: November 19, 2026

## Trials

The 25 newest of 1,276, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 17, 2026 | NCT07941609 | A Study to Investigate the Efficacy and Safety of Dato-DXd-based Combinations in Participants With TROP2 NMR+ NSCLC | AstraZeneca | Phase 2 | Not yet recruiting | Non-small Cell Lung Cancer (NSCLC) | 250 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07941609) |
| November 16, 2026 | NCT07937748 | Filsuvez in Infants With Dystrophic or Junctional Epidermolysis Bullosa | Medical University of South Carolina | Phase 1 | Not yet recruiting | Dystrophic Epidermolysis Bullosa, Junctional Epidermolysis Bullosa | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07937748) |
| November 12, 2026 | NCT07931599 | A Research Study Investigating How Well Zenagamtide at Lower Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide at... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Diabetes Mellitus, Type 2 | 1,060 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931599) |
| November 12, 2026 | NCT07931573 | AMBITION 3: A Research Study Investigating How Well Zenagamtide at Higher Dose Levels Lowers Blood Sugar and Body Weight Compared to... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Type 2 Diabetes | 1,200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931573) |
| November 12, 2026 | NCT07931547 | A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Type 2 Diabetes, Chronic Kidney Disease | 450 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931547) |
| November 9, 2026 | NCT07926321 | A Study to Test Whether BI 3810477 Helps People With Idiopathic Pulmonary Fibrosis When Taken With or Without Standard Treatment | Boehringer Ingelheim | Phase 2 | Not yet recruiting | Idiopathic Pulmonary Fibrosis | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07926321) |
| November 9, 2026 | NCT07924904 | Mindfulness Meditation to Reduce Cognitive Load | University of South Carolina | Not applicable | Not yet recruiting | Test Anxiety, Stress, Psychological, Cognitive Aging | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07924904) |
| November 6, 2026 | NCT07923591 | Study of Treprostinil Administered Via Soft Mist Inhaler (SMI) in Participants With Pulmonary Hypertension Associated With Chronic... | United Therapeutics | Phase 2 | Not yet recruiting | Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07923591) |
| November 6, 2026 | NCT07923526 | An Open-Label Extension Study to Evaluate Inhaled Treprostinil SMI in Participants With Pulmonary Hypertension Associated With Chronic... | United Therapeutics | Phase 2/3 | Not yet recruiting | Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07923526) |
| November 6, 2026 | NCT07922590 | A MRT to Optimize a JITAI for Alcohol Craving and Suicide Ideation | Medical University of South Carolina | Not applicable | Not yet recruiting | Alcohol Use Disorder (AUD), Suicide Ideation | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07922590) |
| November 5, 2026 | NCT07919405 | A Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Hypertension, Obesity | 1,408 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07919405) |
| November 4, 2026 | NCT07915791 | A Study to Assess the Efficacy and Safety of Co-administration of GSK3862995B With GSK5784283 in Adult Participants With Moderate to Severe... | GlaxoSmithKline | Phase 2 | Recruiting | Pulmonary Disease, Chronic Obstructive | 279 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07915791) |
| November 4, 2026 | NCT07915219 | A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON) | Boehringer Ingelheim | Phase 3 | Not yet recruiting | Bronchiectasis | 1,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07915219) |
| November 3, 2026 | NCT07913542 | N-Acetylcysteine for Bipolar and Alcohol Use Disorders | Medical University of South Carolina | Phase 2 | Not yet recruiting | Bipolar Disorder, Alcohol Use Disorder | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07913542) |
| November 2, 2026 | NCT07908381 | A Study to Investigate the Efficacy and Safety of Zelicapavir Compared With Placebo in Adults With RSV Who Are at High Risk for Severe... | Enanta Pharmaceuticals, Inc | Phase 2/3 | Recruiting | RSV | 860 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07908381) |
| October 30, 2026 | NCT07907991 | The AIRWARD Study: A Study to Test Whether Verducatib Helps People With Chronic Obstructive Pulmonary Disease | Boehringer Ingelheim | Phase 3 | Not yet recruiting | Chronic Obstructive Pulmonary Disease | 1,800 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07907991) |
| October 30, 2026 | NCT07907783 | Phase 2 Efficacy and Safety of PP405 in Adult Females With Androgenetic Alopecia | Pelage Pharmaceuticals, Inc. | Phase 2 | Recruiting | Androgenetic Alopecia | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07907783) |
| October 29, 2026 | NCT07903311 | Iron Repletion in Cystic Fibrosis | University of Michigan | Phase 4 | Not yet recruiting | Cystic Fibrosis, Iron Deficiencies, Iron Deficiency Diseases | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07903311) |
| October 29, 2026 | NCT07902843 | Methylprednisolone Taper is an Effective Addition to Multimodal Pain Regimens After Rotator Cuff Repair | The Hawkins Foundation | Phase 4 | Not yet recruiting | Shoulder | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07902843) |
| October 28, 2026 | NCT07901751 | Study to Evaluate the Efficacy of a Single Intravitreal Injection of RTx-015 in Participants With Retinitis Pigmentosa (PERCEPT) | Ray Therapeutics, Inc. | Phase 2/3 | Recruiting | Retinitis Pigmentosa (RP), Inherited Retinal Diseases | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07901751) |
| October 27, 2026 | NCT07898072 | Safety and Efficacy of Weekly Testosterone Cypionate Auto-Injector in Men With Hypogonadism | Amneal Pharmaceuticals, LLC | Phase 3 | Recruiting | Male Hypogonadism | 190 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07898072) |
| October 26, 2026 | NCT07896213 | Metabolically Fit CD19 CAR T Cells With CD34 Selection Markers in Adults With CD19-Positive B-Cell Acute Lymphocytic Leukemia | Medical University of South Carolina | Phase 1 | Not yet recruiting | CD19 Positive, B-ALL, B-cell Acute Lymphocytic Leukemia, Chimeric Antigen Receptor T-cell, CAR-T Cell Therapy, MRD... | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07896213) |
| October 23, 2026 | NCT07891741 | Study of 3D Ultrasound for Support of Hemodialysis Cannulation | Sonavex, Inc. | Not applicable | Recruiting | Dialysis | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07891741) |
| October 22, 2026 | NCT07890376 | A Study to Investigate the Effect of LY4086940 Versus Placebo in Participants With Obesity or Overweight and Without Type 2 Diabetes | Eli Lilly and Company | Phase 2 | Not yet recruiting | Obesity, Overweight | 460 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07890376) |
| October 21, 2026 | NCT07886268 | A Study to Evaluate the Efficacy and Safety of TP-06 for PCED | Tarsus Pharmaceuticals, Inc. | Phase 2 | Recruiting | Persistent Corneal Epithelial Defect | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07886268) |

## Sites with the most of these trials

Sites as the records name them, organizations only.

| Site | City | Trials |
| --- | --- | --- |
| Medical University of South Carolina | Charleston | 397 |
| Prisma Health Cancer Institute - Faris | Greenville | 50 |
| Prisma Health Cancer Institute - Eastside | Greenville | 50 |
| Prisma Health Cancer Institute - Seneca | Seneca | 46 |
| Prisma Health Cancer Institute - Spartanburg | Boiling Springs | 45 |
| Prisma Health Cancer Institute - Butternut | Greenville | 45 |
| Prisma Health Cancer Institute - Greer | Greer | 44 |
| Prisma Health Cancer Institute - Easley | Easley | 42 |
| Prisma Health Richland Hospital | Columbia | 37 |
| Spartanburg Medical Center | Spartanburg | 33 |
| Prisma Health | Greenville | 33 |
| Carolina Urologic Research Center | Myrtle Beach | 32 |
| BI-LO Charities Children's Cancer Center | Greenville | 30 |
| Gibbs Cancer Center-Pelham | Greer | 28 |
| Prisma Health Greenville Memorial Hospital | Greenville | 27 |
| Gibbs Cancer Center-Gaffney | Gaffney | 26 |
| Medical University of South Carolina (MUSC) | Charleston | 26 |
| University of South Carolina | Columbia | 24 |
| SMC Center for Hematology Oncology Union | Union | 24 |
| Ralph H. Johnson VA Medical Center, Charleston, SC | Charleston | 20 |
| Saint Francis Hospital | Greenville | 15 |
| South Carolina Cancer Specialists PC | Hilton Head Island | 15 |
| Levine Cancer Institute-Rock Hill | Rock Hill | 12 |
| Tidelands Georgetown Memorial Hospital | Georgetown | 12 |
| Saint Francis Cancer Center | Greenville | 12 |

## By phase

| Phase | Trials |
| --- | --- |
| Early phase 1 | 11 |
| Phase 1 | 59 |
| Phase 1/2 | 47 |
| Phase 2 | 225 |
| Phase 2/3 | 47 |
| Phase 3 | 412 |
| Phase 4 | 35 |
| Not applicable | 288 |
| Observational | 152 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Obesity | 49 |
| Prostatic Neoplasms | 46 |
| Neoplasms | 39 |
| Carcinoma, Non-Small-Cell Lung | 38 |
| Heart Failure | 35 |
| Overweight | 34 |
| Stroke | 30 |
| Breast Neoplasms | 25 |
| Squamous Cell Carcinoma of Head and Neck | 24 |
| Lung Neoplasms | 24 |
| Diabetes Mellitus, Type 2 | 23 |
| Cardiovascular Diseases | 21 |
| Pulmonary Disease, Chronic Obstructive | 21 |
| Depression | 20 |
| Ovarian Neoplasms | 19 |
| Stress Disorders, Post-Traumatic | 19 |
| Hypertension | 18 |
| Urinary Bladder Neoplasms | 18 |
| Neoplasm Metastasis | 17 |
| Colorectal Neoplasms | 17 |
| Leukemia, Myeloid, Acute | 16 |
| Crohn Disease | 15 |
| Non-Muscle Invasive Bladder Neoplasms | 15 |
| Lung Diseases | 14 |
| Parkinson Disease | 14 |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Medical University of South Carolina | 143 |
| [AstraZeneca](https://specstream.ai/data/clinical-trials/company/astrazeneca) | 46 |
| National Cancer Institute (NCI) | 40 |
| [Eli Lilly and Company](https://specstream.ai/data/clinical-trials/company/eli-lilly-and-company) | 30 |
| University of South Carolina | 27 |
| [Pfizer](https://specstream.ai/data/clinical-trials/company/pfizer) | 25 |
| VA Office of Research and Development | 21 |
| SWOG Cancer Research Network | 20 |
| [Novo Nordisk A/S](https://specstream.ai/data/clinical-trials/company/novo-nordisk-a-s) | 20 |
| Alliance for Clinical Trials in Oncology | 18 |
| Children's Oncology Group | 18 |
| NRG Oncology | 17 |
| [Janssen Research & Development, LLC](https://specstream.ai/data/clinical-trials/company/janssen-research-and-development-llc) | 17 |
| [Boehringer Ingelheim](https://specstream.ai/data/clinical-trials/company/boehringer-ingelheim) | 16 |
| [GlaxoSmithKline](https://specstream.ai/data/clinical-trials/company/glaxosmithkline) | 16 |
| [Merck Sharp & Dohme LLC](https://specstream.ai/data/clinical-trials/company/merck-sharp-and-dohme-llc) | 15 |
| [Takeda](https://specstream.ai/data/clinical-trials/company/takeda) | 15 |
| [Sanofi](https://specstream.ai/data/clinical-trials/company/sanofi) | 14 |
| [Novartis Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/novartis-pharmaceuticals) | 13 |
| [AbbVie](https://specstream.ai/data/clinical-trials/company/abbvie) | 13 |
| [Amgen](https://specstream.ai/data/clinical-trials/company/amgen) | 12 |
| [Hoffmann-La Roche](https://specstream.ai/data/clinical-trials/company/hoffmann-la-roche) | 12 |
| [Bristol-Myers Squibb](https://specstream.ai/data/clinical-trials/company/bristol-myers-squibb) | 10 |
| Duke University | 9 |
| ECOG-ACRIN Cancer Research Group | 8 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in South Carolina

- [Italian restaurants in South Carolina, United States](https://specstream.ai/data/businesses/italian-restaurants/south-carolina-united-states)
- [Audiology clinics in South Carolina, United States](https://specstream.ai/data/businesses/audiology-clinics/south-carolina-united-states)
- [Medical supply stores in South Carolina, United States](https://specstream.ai/data/businesses/medical-supply-stores/south-carolina-united-states)
- [Buffet restaurants in South Carolina, United States](https://specstream.ai/data/businesses/buffet-restaurants/south-carolina-united-states)
- [Orthodontics practices in South Carolina, United States](https://specstream.ai/data/businesses/orthodontics-practices/south-carolina-united-states)
- [Civil engineering firms in South Carolina, United States](https://specstream.ai/data/businesses/civil-engineering-firms/south-carolina-united-states)
